𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells

✍ Scribed by Nicola Normanno; Antonella De Luca; Caterina Bianco; Monica R. Maiello; Maria V. Carriero; Aasia Rehman; Christian Wechselberger; Claudio Arra; Luigi Strizzi; Michele Sanicola; David S. Salomon

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
206 KB
Volume
198
Category
Article
ISSN
0021-9541

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Cripto‐1 (CR‐1) is an epidermal growth factor (EGF)‐CFC protein that has been shown to signal through nodal/Alk‐4, PI3K/Akt, and/or ras/raf/MEK/MAPK pathways in mammalian cells, and that is frequently expressed in human primary breast carcinomas. In the present study, the human estrogen receptor positive, MCF‐7 breast cancer cell line, that expresses low levels of endogenous CR‐1, was transfected with a CR‐1 expression vector. MCF‐7 CR‐1 cells expressed high levels of a 25 kDa recombinant CR‐1 protein that was not detected in MCF‐7 cells transfected with a control vector (MCF‐7 neo). Overexpression of CR‐1 did not induce an estrogen independent phenotype in MCF‐7 cells. In fact, MCF‐7 CR‐1 cells showed a response to exogenous estrogens that was similar to MCF‐7 neo cells, and failed to grow in immunosuppressed mice in absence of estrogen stimulation. However, MCF‐7 CR‐1 cells showed a rate of proliferation in serum free conditions, and an ability to form colonies in soft‐agar that were higher as compared with MCF‐7 neo cells. More importantly, overexpression of CR‐1 enhanced the resistance to anoikis and the invasion ability of MCF‐7 cells. MCF‐7 CR‐1 cells showed levels of activation of both Akt and Smad‐2 that were significantly higher as compared with MCF‐7 neo. These findings suggest that CR‐1 overexpression might be associated with the progression towards a more aggressive phenotype in breast carcinoma, through the activation of both Akt and Smad‐2 signalling pathways. J. Cell. Physiol. 198: 31–39, 2004. © 2003 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Overexpression of bax sensitizes human b
Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis
✍ Chouhei Sakakura; Elizabeth A. Sweeney; Tsutomu Shirahama; Yasuyuki Igarashi; Se 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 553 KB

Resistance to apoptosis plays an important role in tumors that are refractory to chemotherapy and ionizing radiation (IR). bax, which forms a heterddimer with bcl-2 and accelerates apoptosir, is not, or only weakly. expremed in most human breast cancer cells, and weak bax expression is considered to

ZD1839 (IRESSA), an EGFR-selective tyros
ZD1839 (IRESSA), an EGFR-selective tyrosine kinase inhibitor, enhances taxane activity in bcl-2 overexpressing, multidrug-resistant MCF-7 ADR human breast cancer cells
✍ Fortunato Ciardiello; Rosa Caputo; Gaetano Borriello; Donatella Del Bufalo; Anna 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 339 KB

## Abstract Constitutive bcl‐2 overexpression increases the tumorigenic and metastatic potential of doxorubicin‐resistant, estrogen‐independent, MCF‐7 ADR human breast cancer cells. We evaluated the sensitivity to taxanes (paclitaxel, docetaxel and IDN 5109) of 2 bcl‐2‐overexpressing MCF‐7 ADR clon

A shift from normal to high glucose leve
A shift from normal to high glucose levels stimulates cell proliferation in drug sensitive MCF-7 human breast cancer cells but not in multidrug resistant MCF-7/ADR cells which overproduce PKC-βII
✍ Mayumi Yamamoto; Niketa A. Patel; Jennifer Taggart; Rajagopalan Sridhar; Denise 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 651 KB

## Glucose concentration may be an important factor in breast cancer cell proliferation because the prevalence of breast cancer is high in diabetic patients. To determine the role of protein kinase C (PKC)-␤II in regulating MCF-7 cell proliferation at different glucose concentrations, the effects o

Annamycin circumvents resistance mediate
Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposide
✍ Roman Perez-Soler; Nouri Neamati; Yiyu Zou; Erasmus Schneider; L. Austin Doyle; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 144 KB 👁 2 views

Annamycin (Ann) is a highly lipophilic anthracycline antibiotic that has been shown to circumvent MDR-1 both in vitro and in vivo. A liposomal formulation of Ann is currently in phase I clinical trials. The multidrug resistance-associated protein (MRP) has been found to be over-expressed in some hum

The potent anti-proliferative effect of
The potent anti-proliferative effect of 20-EPI analogues of 1,25 dihydroxyvitamin D3 in human breast-cancer MCF-7 cells is related to promoter selectivity
✍ Christina Mørk Hansen; Carina Danielsson; Carsten Carlberg 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 458 KB 👁 1 views

The hormone I ,25-dihydroxyvitamin D3 (VD) has a potential use as an anti-tumor agent, but its clinical applications are restricted by its strong calcemic activity. This has led to the development of VD analogues with selectively increased growthinhibitory activity. One of the most potent analogues